According to a study that combined data from multiple Danish demographic
and health registries, oral hormone therapy for menopausal women was
associated with an increased risk of hospitalization for depression.
The researchers found that the risk was greatest among women 45–50 years
old and in the first years after beginning hormone therapy, but the link
steadily faded after that.
and health registries, oral hormone therapy for menopausal women was
associated with an increased risk of hospitalization for depression.
The researchers found that the risk was greatest among women 45–50 years
old and in the first years after beginning hormone therapy, but the link
steadily faded after that.
